Quantum Surgical, a French company building new minimally invasive surgical tools for cancer, completed an initial investment from Ally Bridge Group, a China-centered healthcare investor. Quantum said the investment is the first part of a $50 million Series A round. The company is developing a robotic platform to improve physicians’ ability to assess, plan and treat a broad spectrum of medical conditions, especially early-stage cancer. Lifetech Scientific, a China medical device company, also participated in the investment through its JV with ABG and will collaborate with Quantum Surgical in the China market.
Source: China Biotoday
